Time To Launch Now Skip to main content

Posts

Showing posts with the label effective

How does fiber make the stomach feel 'light'?

 How does fiber make the stomach feel 'light'? Fiber is a type of carbohydrate—existing in both soluble and insoluble forms—that can help alleviate constipation and promote regular bowel movements. Fiber is a carbohydrate that our digestive system cannot fully digest; consequently, it mostly passes through the digestive tract and is eliminated from the body. This characteristic allows fiber to play a crucial role in the health of the stomach and intestines. There are two types of fiber: soluble and insoluble. Soluble fiber mixes with water to form a gel-like substance. It can help slow down digestion, regulate blood sugar levels , and assist in managing cholesterol. Foods such as oats , barley, apples, oranges, beans, and peas contain soluble fiber. Insoluble fiber, on the other hand, does not dissolve in water. It adds bulk to the stool and helps it move smoothly through the intestines. Wheat bran , whole grains, certain vegetables, fruit skins, and nuts contain this type of...

GSK's drug is 60 percent more effective in curing cancer in women

 GSK's drug is 60 percent more effective in curing cancer in women World-renowned pharmaceutical company GSK has announced that the initial results of its new drug ' Mosertatag Rezedacan ', which is used to treat uterine and ovarian cancer , are encouraging. In the first phase of clinical trials, 'Mosertatag Rezedacan' has shown success in platinum-resistant ovarian cancer by 62 percent and in uterine cancer by 67 percent. GSK is preparing to start five large 'Phase-3' clinical trials in 2026 and the drug could change the way cancer is treated, said Hesham Abdullah. World-renowned pharmaceutical company GSK has announced that the initial results of its new drug used to treat uterine and ovarian cancer are very encouraging. The new antibody-drug conjugate (ADC) drug , called mosertatag rezedecan, has shown positive results in a phase 1 clinical trial. The BEHOLD-1 study , presented at the Society of Gynecologic Oncology (SGO) annual meeting in Puerto Rico, ...